Dario Trapani, Medical Oncologist at European Institute of Oncology, shared a post on LinkedIn:
“This morning, I had the privilege of participating in a crucial discussion at London Global Cancer Week!
​It was an honor to join colleagues and experts to explore the critical intersection of value and decision-making in global cancer care.
We dug deep into how we can genuinely use a framework of value to drive better decisions that – including the ESMO MCBS, in turn, shape equitable access to life-saving diagnostics and treatments.
Specifically, we focused on the monumental challenges and opportunities in Low- and Middle-Income Countries while also examining the global implications of these decisions.
It’s not just about what is clinically effective; it’s about what is humanely effective, what truly delivers quality of life and sustainable systems.
Our conversation was a powerful reminder that behind every policy and every resource allocation decision is a human life and a family depending on that care.”
​Thank you to the organizers of LGCW for facilitating this vital dialogue. Let’s keep the momentum going to ensure that a commitment to value translates into tangible, equitable access for everyone, everywhere.
Can’t be more grateful to Olubukola Ayodele for considering me, the LGCW is a unique opportunity for the entire community to gather at all levels in a confidential and open format , where I could meet many people marking a difference in global cancer control!”
Quoting Rad Chat’s post:
“Next session chaired by Prof. Ophira Ginsburg looking at innovation in cancer treatment and equity.
Insightful and eye opening talk from Dr. Dario Trapani on how to ensure emerging treatments reach all populations – may countries have no access to immunotherapies!”
More posts featuring Dario Trapani.
